{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:34:38Z","timestamp":1788345278184,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00345-014-1350-1","type":"journal-article","created":{"date-parts":[[2014,6,30]],"date-time":"2014-06-30T23:08:59Z","timestamp":1404169739000},"page":"617-622","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Circumcision plus antibiotic, anti-inflammatory, and \u03b1-blocker therapy for the treatment for chronic prostatitis\/chronic pelvic pain syndrome: a prospective, randomized, multicenter trial"],"prefix":"10.1007","volume":"33","author":[{"given":"Yuyang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genqiang","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaowu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongliang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujie","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,1]]},"reference":[{"key":"1350_CR1","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1464-410X.2004.05148.x","volume":"94","author":"JC Nickel","year":"2004","unstructured":"Nickel JC (2004) The three As of chronic prostatitis therapy: antibiotics, alpha-blockers and anti-inflammatories. What is the evidence? BJU Int 94:1230","journal-title":"BJU Int"},{"key":"1350_CR2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0022-5347(05)63960-2","volume":"169","author":"PY Cheah","year":"2003","unstructured":"Cheah PY, Liong ML, Yuen KH et al (2003) Terazosin therapy for chronic prostatitis\/chronic pelvic pain syndrome: a randomized, placebo controlled trial. J Urol 169:592","journal-title":"J Urol"},{"key":"1350_CR3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.juro.2011.03.028","volume":"186","author":"JC Nickel","year":"2011","unstructured":"Nickel JC, O\u2019Leary MP, Lepor H et al (2011) Silodosin for men with chronic prostatitis\/chronic pelvic pain syndrome: results of a phase II multicenter, double-blind, placebo controlled study. J Urol 186:125","journal-title":"J Urol"},{"key":"1350_CR4","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0090-4295(03)00583-1","volume":"62","author":"JC Nickel","year":"2003","unstructured":"Nickel JC, Downey J, Clark J et al (2003) Levofloxacin for chronic prostatitis\/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology 62:614","journal-title":"Urology"},{"key":"1350_CR5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-141-8-200410190-00005","volume":"141","author":"RB Alexander","year":"2004","unstructured":"Alexander RB, Propert KJ, Schaeffer AJ et al (2004) Ciprofloxacin or tamsulosin in men with chronic prostatitis\/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 141:581","journal-title":"Ann Intern Med"},{"key":"1350_CR6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jama.2010.1913","volume":"305","author":"T Anothaisintawee","year":"2011","unstructured":"Anothaisintawee T, Attia J, Nickel JC et al (2011) Management of chronic prostatitis\/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA 305:78","journal-title":"JAMA"},{"key":"1350_CR7","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1097\/QAD.0b013e328330eda8","volume":"23","author":"G Kigozi","year":"2009","unstructured":"Kigozi G, Wawer M, Ssettuba A et al (2009) Foreskin surface area and HIV acquisition in Rakai, Uganda (size matters). AIDS 23:2209","journal-title":"AIDS"},{"key":"1350_CR8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/mi.2010.18","volume":"3","author":"KM Fahrbach","year":"2010","unstructured":"Fahrbach KM, Barry SM, Anderson MR et al (2010) Enhanced cellular responses and environmental sampling within inner foreskin explants: implications for the foreskin\u2019s role in HIV transmission. Mucosal Immunol 3:410","journal-title":"Mucosal Immunol"},{"key":"1350_CR9","first-page":"395","volume":"15","author":"KL Ben","year":"2009","unstructured":"Ben KL, Xu JC, Lu L et al (2009) Male circumcision is an effective \u201csurgical vaccine\u201d for HIV prevention and reproductive health. Zhonghua Nan Ke Xue 15:395","journal-title":"Zhonghua Nan Ke Xue"},{"key":"1350_CR10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11136-005-1317-1","volume":"15","author":"KJ Propert","year":"2006","unstructured":"Propert KJ, Litwin MS, Wang Y et al (2006) Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Qual Life Res 15:299","journal-title":"Qual Life Res"},{"key":"1350_CR11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-5347(05)68562-X","volume":"162","author":"MS Litwin","year":"1999","unstructured":"Litwin MS, McNaughton-Collins M, Fowler FJ Jr et al (1999) The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 162:369","journal-title":"J Urol"},{"key":"1350_CR12","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1056\/NEJMoa0803240","volume":"359","author":"JC Nickel","year":"2008","unstructured":"Nickel JC, Krieger JN, McNaughton-Collins M et al (2008) Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med 359:2663","journal-title":"N Engl J Med"},{"key":"1350_CR13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000112606","volume":"80","author":"CW Jeong","year":"2008","unstructured":"Jeong CW, Lim DJ, Son H et al (2008) Treatment for chronic prostatitis\/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination. Urol Int 80:157","journal-title":"Urol Int"},{"key":"1350_CR14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/147323000803600205","volume":"36","author":"ZQ Ye","year":"2008","unstructured":"Ye ZQ, Lan RZ, Yang WM et al (2008) Tamsulosin treatment of chronic non-bacterial prostatitis. J Int Med Res 36:244","journal-title":"J Int Med Res"},{"key":"1350_CR15","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1464-410X.2012.11088.x","volume":"110","author":"A Thakkinstian","year":"2012","unstructured":"Thakkinstian A, Attia J, Anothaisintawee T et al (2012) Alpha-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis\/chronic pelvic pain syndrome. BJU Int 110:1014","journal-title":"BJU Int"},{"key":"1350_CR16","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.eururo.2006.09.036","volume":"51","author":"V Tugcu","year":"2007","unstructured":"Tugcu V, Tasci AI, Fazlioglu A et al (2007) A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS). Eur Urol 51:1113","journal-title":"Eur Urol"},{"issue":"Suppl 1","key":"1350_CR17","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/j.ijantimicag.2007.08.027","volume":"31","author":"AJ Schaeffer","year":"2008","unstructured":"Schaeffer AJ (2008) Epidemiology and evaluation of chronic pelvic pain syndrome in men. Int J Antimicrob Agents 31(Suppl 1):S108","journal-title":"Int J Antimicrob Agents"},{"key":"1350_CR18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1258\/0956462053420239","volume":"16","author":"D Goldmeier","year":"2005","unstructured":"Goldmeier D, Madden P, McKenna M et al (2005) Treatment of category III A prostatitis with zafirlukast: a randomized controlled feasibility study. Int J STD AIDS 16:196","journal-title":"Int J STD AIDS"},{"key":"1350_CR19","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/eji.200838521","volume":"38","author":"AL Cunningham","year":"2008","unstructured":"Cunningham AL, Carbone F, Geijtenbeek TB (2008) Langerhans cells and viral immunity. Eur J Immunol 38:2377","journal-title":"Eur J Immunol"},{"key":"1350_CR20","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1084\/jem.20061884","volume":"203","author":"M Chieppa","year":"2006","unstructured":"Chieppa M, Rescigno M, Huang AY et al (2006) Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J Exp Med 203:2841","journal-title":"J Exp Med"},{"key":"1350_CR21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2796.2008.02046.x","volume":"265","author":"MA Jong de","year":"2009","unstructured":"de Jong MA, Geijtenbeek TB (2009) Human immunodeficiency virus-1 acquisition in genital mucosa: Langerhans cells as key-players. J Intern Med 265:18","journal-title":"J Intern Med"},{"key":"1350_CR22","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.ju.0000082252.49374.e9","volume":"170","author":"JC Nickel","year":"2003","unstructured":"Nickel JC, Alexander RB, Schaeffer AJ et al (2003) Leukocytes and bacteria in men with chronic prostatitis\/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol 170:818","journal-title":"J Urol"},{"key":"1350_CR23","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0022-5347(05)63958-4","volume":"169","author":"JC Lee","year":"2003","unstructured":"Lee JC, Muller CH, Rothman I et al (2003) Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls. J Urol 169:584","journal-title":"J Urol"},{"key":"1350_CR24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000052415","volume":"39","author":"H John","year":"2001","unstructured":"John H, Barghorn A, Funke G et al (2001) Noninflammatory chronic pelvic pain syndrome: immunological study in blood, ejaculate and prostate tissue. Eur Urol 39:72","journal-title":"Eur Urol"},{"key":"1350_CR25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-3083.2007.01971.x","volume":"66","author":"RD Motrich","year":"2007","unstructured":"Motrich RD, Maccioni M, Riera CM et al (2007) Autoimmune prostatitis: state of the art. Scand J Immunol 66:217","journal-title":"Scand J Immunol"},{"key":"1350_CR26","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1016\/j.juro.2009.07.067","volume":"182","author":"DV Kouiavskaia","year":"2009","unstructured":"Kouiavskaia DV, Southwood S, Berard CA et al (2009) T-cell recognition of prostatic peptides in men with chronic prostatitis\/chronic pelvic pain syndrome. J Urol 182:2483","journal-title":"J Urol"},{"key":"1350_CR27","doi-asserted-by":"crossref","first-page":"e1002100","DOI":"10.1371\/journal.ppat.1002100","volume":"7","author":"Z Zhou","year":"2011","unstructured":"Zhou Z, Barry de Longchamps N, Schmitt A et al (2011) HIV-1 efficient entry in inner foreskin is mediated by elevated CCL5\/RANTES that recruits T cells and fuels conjugate formation with Langerhans cells. PLoS Pathog 7:e1002100","journal-title":"PLoS Pathog"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-014-1350-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-014-1350-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-014-1350-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:40:15Z","timestamp":1559050815000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-014-1350-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,1]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1350"],"URL":"https:\/\/doi.org\/10.1007\/s00345-014-1350-1","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,1]]}}}